Literature DB >> 10536674

Chronic regulation of arterial blood pressure in ANP transgenic and knockout mice: role of cardiovascular sympathetic tone.

L G Melo1, A T Veress, U Ackermann, M E Steinhelper, S C Pang, Y Tse, H Sonnenberg.   

Abstract

OBJECTIVE: Atrial natriuretic peptide (ANP) lowers arterial blood pressure (ABP) chronically, in association with vasodilation of the resistance vasculature. The mechanism mediating the chronic relaxant effect of ANP is likely indirectly mediated by interactions with tonic vasoeffector mechanisms, inasmuch as the resistance vasculature is relatively insensitive to direct cGMP-mediated relaxation by ANP. On the basis of evidence that ANP has widespread sympatholytic activity, the current study investigated whether the chronic hypotensive effect of ANP is mediated by attenuation of tonic cardiovascular sympathetic tone.
METHODS: Total plasma catecholamine concentration and changes in basal ABP and heart rate (HR) following autonomic ganglionic blockade were measured as indices of underlying sympathetic nerve activity in hypotensive ANP-overexpressing transgenic mice (TTR-ANP), hypertensive ANP knockout mice (-/-) and the genetically-matched wild type (NT and +/+, respectively) control mice. Pressor and chronotropic responses to norepinephrine infusion were measured in ganglion-blocked mice of all genotypes, and norepinephrine receptor binding was assessed in representative tissues of -/- and +/+ mice, in order to determine whether peripheral adrenergic receptor responsiveness is altered by ANP-genotype.
RESULTS: Basal ABP was significantly lower in TTR-ANP and higher in -/- compared to their wild-type controls. Basal HR did not differ significantly between mutant and control mice. Autonomic ganglionic blockade reduced ABP and HR in all genotypes, however, the relative decrease in ABP was significantly smaller in TTR-ANP and greater in -/- mice than in their respective controls. Total plasma catecholamine was significantly higher in -/- than in +/+ mice but did not differ significantly between TTR-ANP and NT mice. Norepinephrine infusion during ganglionic blockade elicited quantitatively similar pressor and chronotropic responses in mutant and control mice. Tissue norepinephrine binding did not differ significantly between -/- and +/+ mice.
CONCLUSIONS: The present study shows that differences in endogenous ANP activity in mice, resulting in chronic alterations in ABP are accompanied by directional changes in underlying cardiovascular sympathetic tone, and suggests that the chronic vasodilator effect of ANP is, at least partially, dependent on attenuation of vascular sympathetic tone, possibly at a prejunctional site(s).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10536674     DOI: 10.1016/s0008-6363(99)00104-2

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  13 in total

Review 1.  Guanylyl cyclase / atrial natriuretic peptide receptor-A: role in the pathophysiology of cardiovascular regulation.

Authors:  Kailash N Pandey
Journal:  Can J Physiol Pharmacol       Date:  2011-08-04       Impact factor: 2.273

Review 2.  The functional genomics of guanylyl cyclase/natriuretic peptide receptor-A: perspectives and paradigms.

Authors:  Kailash N Pandey
Journal:  FEBS J       Date:  2011-04-07       Impact factor: 5.542

3.  Progressive cardiac hypertrophy and dysfunction in atrial natriuretic peptide receptor (GC-A) deficient mice.

Authors:  M Kuhn; R Holtwick; H A Baba; J C Perriard; W Schmitz; E Ehler
Journal:  Heart       Date:  2002-04       Impact factor: 5.994

4.  Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure.

Authors:  Rita Holtwick; Michael Gotthardt; Boris Skryabin; Martin Steinmetz; Regine Potthast; Bernd Zetsche; Robert E Hammer; Joachim Herz; Michaela Kuhn
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

5.  Evidence for a novel natriuretic peptide receptor that prefers brain natriuretic peptide over atrial natriuretic peptide.

Authors:  M F Goy; P M Oliver; K E Purdy; J W Knowles; J E Fox; P J Mohler; X Qian; O Smithies; N Maeda
Journal:  Biochem J       Date:  2001-09-01       Impact factor: 3.857

6.  Disruption of Npr1 gene differentially regulates the juxtaglomerular and distal tubular renin levels in null mutant mice.

Authors:  Minolfa C Prieto; Subhankar Das; Naveen K Somanna; Lisa M Harrison-Bernard; L Gabriel Navar; Kailash N Pandey
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-09-20

7.  Emerging Roles of Natriuretic Peptides and their Receptors in Pathophysiology of Hypertension and Cardiovascular Regulation.

Authors:  Kailash N Pandey
Journal:  J Am Soc Hypertens       Date:  2008 Jul-Aug

Review 8.  Molecular and genetic aspects of guanylyl cyclase natriuretic peptide receptor-A in regulation of blood pressure and renal function.

Authors:  Kailash N Pandey
Journal:  Physiol Genomics       Date:  2018-08-31       Impact factor: 3.107

9.  Blood sampling methodology is crucial for precise measurement of plasma catecholamines concentrations in mice.

Authors:  Eric Grouzmann; Claudia Cavadas; Daniela Grand; Martine Moratel; Jean-François Aubert; Hans R Brunner; Lucia Mazzolai
Journal:  Pflugers Arch       Date:  2003-08-05       Impact factor: 3.657

Review 10.  Effects of moxonidine on sympathetic nervous system activity: An update on metabolism, cardio, and other target-organ protection.

Authors:  Eleni F Karlafti; Apostolos I Hatzitolios; Anastasios F Karlaftis; Maria S Baltatzi; Georgios G Koliakos; Christos G Savopoulos
Journal:  J Pharm Bioallied Sci       Date:  2013-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.